Picture

Jerome Scelza @JScelza

🧠 3X Founder/Operator/Johns Hopkins trained Bioengineer. Matt Serra BJJ Blue Belt ⚔️ lumendiagnostics.com New York, NY Joined October 2013
  • Tweets
    2K
  • Followers
    453
  • Following
    3K
  • Likes
    19K
JScelza Profile Picture

Jerome Scelza @JScelza

20 hours ago

“People are sicker than ever”, “Healthcare costs are higher than ever”, “Payors are more profitable than ever”. And 85% of it? Chronic illness that comes down to lifestyle. Stop blaming the system. Stop waiting for a savior. It’s you. Not them.

Jerome Scelza retweeted
aakashg0 Profile Picture

Aakash Gupta @aakashg0

2 days ago

"Our marketing team is just me and ~40 AI agents." -Million-dollar founder with no marketing team Want the template? Retweet + Reply and I'll DM you.

JScelza Profile Picture

Jerome Scelza @JScelza

5 days ago

Cool gadgets don’t save lives — speed does. I’m deploying tens of millions to move diagnostics from bench to ER in 12 months. If your tech cuts time-to-treatment by 50%+, DM me. I’ll handle the regulatory grind, scaling and go-to-market so clinicians can treat faster.

JScelza Profile Picture

Jerome Scelza @JScelza

5 days ago

Stop building features. Solve one clear clinical problem so regulators, clinicians and payers can't ignore it. I'm deploying tens of millions to startups that prove real‑world impact fast — if you can't show better patient outcomes in 90 days, you're selling hope, not a product.

JScelza Profile Picture

Jerome Scelza @JScelza

5 days ago

Raised tens of millions building med‑tech startups: real lesson—VCs don’t buy ideas, they buy repeatable outcomes. Solve one tight clinical problem, prove it in 10 patients, then scale. FDA clears evidence, not perfection. Ship fast, learn faster, metrics follow.

JScelza Profile Picture

Jerome Scelza @JScelza

5 days ago

I've raised tens of millions and cleared devices at the FDA. Brutal truth: if your med device doesn't change a clinician's action, payer payment, or patient outcome, it's a demo — not a business. Build for decisions, reimbursement, and outcome impact before you prototype.

JScelza Profile Picture

Jerome Scelza @JScelza

5 days ago

As a Johns Hopkins-trained biomedical engineer who’s raised tens of millions: medtech wins when you trade "cool" demos for deployable tools that change clinician workflow, lower cost, and survive regulatory scrutiny. Funders follow outcomes, not slides.

JScelza Profile Picture

Jerome Scelza @JScelza

5 days ago

Stop building "better tech." Build faster adoption. In medtech the moat isn't IP — it's clinical adoption, reimbursement, and scale. Prove a clinical win, lock a payer pathway, then raise. Investors buy adoption, not optimism. Ship outcomes, not slides.

JScelza Profile Picture

Jerome Scelza @JScelza

5 days ago

Raised tens of millions, launched med devices and earned FDA clearances. One truth: investors buy repeatable behavior, not specs. If your product doesn't change clinician workflow or create a billable moment, it's a demo — not a company. Build for adoption.

JScelza Profile Picture

Jerome Scelza @JScelza

5 days ago

Johns Hopkins biomedical engineer here: startups don't win on 'cool tech' — they win on replaceable cost. Design to get covered by payers first, prove clinical ROI, then scale. Build outcomes > features and the funding follows.

JScelza Profile Picture

Jerome Scelza @JScelza

6 days ago

Built startups from lab to FDA clearance and raised tens of millions. Hot take: the next big win isn’t AI alone — it’s clinical-grade, pocketable devices that turn days of diagnostics into minutes and cut costs 10x. We’re building one. Investors, clinicians, champions — join us.

JScelza Profile Picture

Jerome Scelza @JScelza

6 days ago

As a Johns Hopkins-trained engineer who’s helped raise tens of millions: founders — stop selling features, start shipping life‑saving outcomes. Funders follow impact; clinicians deploy it. Build for workflows, hire nurses early, and the market will follow.

JScelza Profile Picture

Jerome Scelza @JScelza

6 days ago

I remember the first prototype — a $12 sensor taped to an ICU bed. We raised tens of millions, fought the FDA, and turned that rag-tag idea into an FDA-cleared device used in hospitals. Stop funding slide decks. Fund founders who ship clinical outcomes. Ready to build?

JScelza Profile Picture

Jerome Scelza @JScelza

6 days ago

I've raised tens of millions, built medtech startups and secured FDA clearances. Want to win in medtech/biotech? Stop selling 'cool tech' and focus on 3 things: reproducible clinical outcomes, a clear reimbursement path, and a buyer who'll risk budget. Ship for workflow.

JScelza Profile Picture

Jerome Scelza @JScelza

6 days ago

Built med devices, raised tens of millions, won FDA clearances. Blunt truth: "AI" gets headlines, not prescriptions. Winners build simple tools that fit clinician workflow, change decisions, prove outcomes, and secure reimbursement. Ship usefulness, not complexity.

JScelza Profile Picture

Jerome Scelza @JScelza

6 days ago

VCs don’t buy AI, they buy demonstrated outcomes. If your med device or diagnostic can’t cut cost, shorten LOS, or improve actionable diagnosis, it’s a demo reel. Design trials around payer savings and clinician workflow — then raise. Build outcomes, not buzz.

JScelza Profile Picture

Jerome Scelza @JScelza

6 days ago

Founders obsess over features; investors buy de‑risking. Run one brutal experiment that can kill your medtech hypothesis fast—if it survives, you’ve found real product-market fit. Clinical validation > launch parties. Spend your runway proving you’re real.

JScelza Profile Picture

Jerome Scelza @JScelza

6 days ago

Founders: stop building cool lab gadgets. Build diagnostics that live in clinics, plug into EHRs, and get paid for outcomes. Sensors + LLMs = early disease interception. If you can't prove saved dollars and days, you won't scale.

Jerome Scelza retweeted
pmitu Profile Picture

Paul Mit @pmitu

6 days ago

What early PMF looks like: 1/ People send you a lot of bug reports 2/ Angry public posts about app issues appear on X and Li 3/ Users suggest feature requests and redesign the app to fit them 4/ They want a discount instead of refunds 5/ Competitors have copied part of your UI…

Jerome Scelza retweeted
simonmaechling Profile Picture

Simon Maechling @simonmaechling

a week ago

Huntington’s disease is brutal. A single DNA error → toxic protein → dead brain cells. No cure. Always fatal. Always inherited. But now? Science has flipped the script. How the new gene therapy works: 1️⃣ Huntington’s mutation makes a toxic protein that kills neurons. 2️⃣…

Trends for United States

Xbox
65,7 B posts
#Overwatch2Sweepstakes
1.342 posts
Halloween
168 B posts
Demercado
Ubisoft
7.850 posts
Michael Carter
George Valera
Bibee
1.795 posts
Snit
4.235 posts
Chase DeLauter
1.191 posts
Yom Kippur
28,4 B posts
Mize
2.972 posts
Lisa Cook
14,2 B posts
Medicaid
123 B posts
Qatar
108 B posts
#PCEIYA
Sean Tucker
#HazbinHotel
15,7 B posts
Erik Johnson
Pope
46,7 B posts

You might like

Compute deficient.
plugyawn
@plugyawn
155 Followers
If your friends don't like it when you have a different opinion, don't change what you think. Change your friends. I voted for Trump . Get over it 😘 #Trump2020
KeepTexasRed83
@KeepTexasRed83
3K Followers
Cool, gentle but shy
pako masiele
@P_masiele
18 Followers
Author. Writer Arsenal fan ❤️ Assistant Arsenal Manager Christian ☦️
Online Tactico
@osemeiluehimen
278 Followers
Retweet 👑
Ponch
@hola_gatita
53 Followers
Th
@Th34540706
8 Followers
MD, PhD | Computational cardiology | @NU_intmed @PSTP_at_NU ex @tempusai @sinaimstp @uchicago
Kipp Johnson
@kippwjohnson
768 Followers
m a t•m a n
@derMaann_
270 Followers